Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
TCT-Connect-2020-IREMMI-Trial-Rodrigo-Estévez-Loureiro
Added: 3 years ago
Dr Rodrigo Estévez-Loureiro (University Hospital Alvaro Cunqueiro, Vigo, SP) discusses the outcomes of MitraClip in patients with acute mitral regurgitation in AMI with and without cardiogenic shock. Questions 1. What is the background of the study? 2. How did you define cardiogenic shock? 3. What was the design, patient population and endpoints? 4. What were the key results? 5. What… View more

MI/ACS

Intervention
Prof Diana Gorog
Research Area(s) / Expertise:

Thrombosis, embolism & bleeding

Coronary Artery Disease and Myocardial Infarction

 Job title: Cardiologist and Clinical Lead for Non-cancer Research
Prof Diana Gorog holds academic appointments at the University of Hertfordshire and at the National Heart and Lung Institute of Imperial College, London, and is a full-time interventional consultant cardiologist at East and North Hertfordshire NHS Trust, UK. Prof Gorog graduated in Medicine from St. Bartholomew’s Medical School, University of London in1993 and undertook clinical training in… View more
Juan Carlos Kaski
Job title: Professor of Cardiovascular Science
Juan Carlos Kaski is Professor of Cardiovascular Science (Emeritus) at the Molecular and Clinical Sciences Research Institute, St Gorge’s, University of London, and Hon. Consultant Cardiologist at St George’s Hospital and the Royal Brompton Hospital in London, UK. He is Doctor Honoris Causa of several universities worldwide, a past-President of the International Society of Cardiovascular… View more
CardioNerds @AHA23: AZALEA-TIMI 71: Abelcibab Vs Rivaroxaban in Patients with AF
Author(s): Naima Maqsood , Christian Ruff Added: 5 months ago
AHA 23 - Dr Naima Maqsood, CardioNerds ambassador (Temple University Hospital, US) interviews Dr Christian Ruff (Brigham and Women's Hospital, US) on the late-breaking findings from the AZALEA-TIMI 71 randomized trial (Anthos Theraputics, Inc).AZALEA-TIMI 71 aimed to evaluate the bleeding profile of abelacimab as compared to rivaroxaban in patients with atrial fibrillation who are at moderate to… View more

Anticoagulation

Electrophysiology & Arrhythmia
Author(s): Tamar S Polonsky , Victor Mor-Avi , Roberto M Lang Added: 3 years ago
Cardiac imaging has become fully integrated in the management of patients, with echocardiography being the most widely used modality. Two-dimensional echocardiography (2DE) offers a detailed assessment of ventricular function, valvular pathology, and hemodynamics, but its comprehensiveness is limited by the fact that images represent a single plane, and may thus inadequately represent a heart… View more

Imaging & Diagnostics
Author(s): Peter J Fitzgerald , Martin B Leon Added: 3 years ago
An unintended consequence of the market success of drug-eluting stents has been a growing concern about their safety and safety-related costs. These devices have been so quickly and widely adopted that their market penetration already equals that of some of the most popular pharmaceutical drugs. Consequently, the absolute significance of even a low incidence of side effects becomes magnified by… View more

Intervention
Author(s): Rakesh Latchamsetty Added: 3 years ago
Introduction Premature ventricular complexes (PVCs) in the absence of underlying structural heart disease have long been viewed as benign. Early studies with small population sizes and limited cardiac testing suggested that long-term prognosis in patients with idiopathic PVCs is similar to those in patients without other cardiac disease, and treatment was consequently limited to provide… View more

Electrophysiology & Arrhythmia
Author(s): Joost Daemen , Nicolas M Van Mieghem Start date: Nov 15, 2022

Heart Failure

Electrophysiology & Arrhythmia
Cardio-oncology A-Z: Breast Cancer Treatment Related Cardiotoxicity With Dr Anne Blaes
Added: 1 year ago
In this video we invited Dr Anne Blaes, Associate Professor in the Division of Hematology and Oncology at the University of Minnesota, to summarise the topic of breast cancer treatment related cardiotoxicity. Dr Blaes is an active medical oncologist with a special interest in the late effects of cancer therapy. Discussion Points: 1. What are the main cancer treatments that cause this problem? 2… View more

Demographic

CV Disease in Special Populations
Author(s): Barbara J Turner , Tara Lagu Added: 3 years ago
Ischemic heart disease and stroke account for nearly 25% of all deaths worldwide.1 With an increasing array of effective medications for hypertension and hyperlipidemia, the toll exacted by vascular disease should diminish. However, control of these two primary causes of vascular disease has been seriously compromised by under-diagnosis and under-treatment.2,3 National survey data in the US has… View more

Prevention & Chronic Conditions